Literature DB >> 19147097

Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes.

Mohammed Sorror1.   

Abstract

Mesh：

Year:  2009        PMID： 19147097     DOI： 10.1016/j.bbmt.2008.12.498

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  10 in total

1.  Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation.

Authors:  M Sarmiento; R Parody; F Márquez-Malaver; I Espigado; J Falantes; T Caballero; C Calderón; M Carmona; J López Haldon; J A Pérez-Simón
Journal:  Bone Marrow Transplant       Date:  2016-02-08       Impact factor: 5.483

2.  How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT.

Authors:  Olaf Penack; Christophe Peczynski; Mohamad Mohty; Ibrahim Yakoub-Agha; Jan Styczynski; Silvia Montoto; Rafael F Duarte; Nicolaus Kröger; Hélène Schoemans; Christian Koenecke; Zinaida Peric; Grzegorz W Basak
Journal:  Blood Adv       Date:  2020-12-22

Review 3.  Intensive care outcomes in adult hematopoietic stem cell transplantation patients.

Authors:  Ulas D Bayraktar; Joseph L Nates
Journal:  World J Clin Oncol       Date:  2016-02-10

4.  A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia.

Authors:  Theis H Terwey; Philipp G Hemmati; Peter Martus; Ekkehart Dietz; Lam G Vuong; Gero Massenkeil; Bernd Dörken; Renate Arnold
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

5.  Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.

Authors:  José Luis Piñana; Rodrigo Martino; Jorge Gayoso; Anna Sureda; Javier de la Serna; Jose Luis Díez-Martín; Lourdes Vazquez; Reyes Arranz; José Francisco Tomás; Antonia Sampol; Carlos Solano; Julio Delgado; Jorge Sierra; Dolores Caballero
Journal:  Haematologica       Date:  2010-01-27       Impact factor: 9.941

6.  Factors affecting prognosis in myelofibrosis.

Authors:  Francesco Onida
Journal:  F1000 Med Rep       Date:  2009-07-08

Review 7.  The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era.

Authors:  Francesco Maura; Lucia Farina; Paolo Corradini
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-09-01       Impact factor: 2.576

8.  The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.

Authors:  Håkon Reikvam; Kimberley Hatfield; Øystein Bruserud
Journal:  Metabolomics       Date:  2015-11-16       Impact factor: 4.290

9.  Clinical course and end-of-life care in patients who have died after allogeneic stem cell transplantation.

Authors:  Christoph Busemann; Andreas Jülich; Britta Buchhold; Vanessa Schmidt; Laila Schneidewind; Daniel Pink; Christian Andreas Schmidt; Thomas Neumann; William H Krüger
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-27       Impact factor: 4.553

10.  Metabolic Serum Profiles for Patients Receiving Allogeneic Stem Cell Transplantation: The Pretransplant Profile Differs for Patients with and without Posttransplant Capillary Leak Syndrome.

Authors:  Håkon Reikvam; Ida-Sofie Grønningsæter; Aymen Bushra Ahmed; Kimberley Hatfield; Øystein Bruserud
Journal:  Dis Markers       Date:  2015-11-02       Impact factor: 3.434
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.